We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+1.11%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.58B
AUM Growth
+$102M
Cap. Flow
+$70.6M
Cap. Flow %
2.74%
Top 10 Hldgs %
45.91%
Holding
71
New
22
Increased
18
Reduced
11
Closed
19

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$113M
2
HUM icon
Humana
HUM
+$98.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$93.7M
4
ELAN icon
Elanco Animal Health
ELAN
+$93.5M
5
ABT icon
Abbott
ABT
+$80.7M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$136M
2
HAE icon
Haemonetics
HAE
+$99.1M
3
AGN
Allergan plc
AGN
+$90.4M
4
DXCM icon
DexCom
DXCM
+$87M
5
MDT icon
Medtronic
MDT
+$81.3M

Sector Composition

Rank Sector Weight
1 Healthcare 91.39%
2 Technology 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
26
IQVIA
IQV
$39.1B
$41.2M 1.6%
255,944
-146,896
-36% -$20.6M
VRAY
27
DELISTED
ViewRay, Inc.
VRAY
$40.2M 1.56%
4,564,640
+372,090
+9% +$3.02M
CHNG
28
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$39.3M 1.52%
+2,690,190
New +$39.8M
CNMD icon
29
CONMED
CNMD
$1.41B
$39M 1.51%
455,190
+115,690
+34% +$9.51M
BPMC
30
DELISTED
Blueprint Medicines
BPMC
$36.1M 1.4%
+382,504
New +$31.6M
ALNY icon
31
Alnylam Pharmaceuticals
ALNY
$27.5B
$34M 1.32%
+468,540
New +$35.9M
ALC icon
32
Alcon
ALC
$33.9B
$32.7M 1.27%
+526,840
New +$30.9M
BDX icon
33
Becton Dickinson
BDX
$45.6B
$30.6M 1.19%
124,302
-45,151
-27% -$10.5M
RDUS
34
DELISTED
Radius Health, Inc.
RDUS
$30.3M 1.17%
1,242,850
-2,438,099
-66% -$53.3M
BMY icon
35
CALL
Bristol-Myers Squibb
BMY
$132B
$27.2M 1.06%
+600,000
New +$27.9M
CLVS
36
DELISTED
Clovis Oncology, Inc.
CLVS
$24.5M 0.95%
1,648,090
+249,790
+18% +$4.51M
PFE icon
37
PUT
Pfizer
PFE
$142B
$21.7M 0.84%
+527,000
New +$20.9M
MYOK
38
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$17.6M 0.68%
350,620
-380,140
-52% -$18.5M
STML
39
DELISTED
Stemline Therapeutics, Inc.
STML
$16.4M 0.64%
+1,069,960
New +$15.5M
SEM
40
DELISTED
Select Medical
SEM
$15.9M 0.62%
1,865,094
+751,494
+67% +$5.94M
NUVA
41
DELISTED
NuVasive, Inc.
NUVA
$14.6M 0.57%
+249,720
New +$14.7M
CNC icon
42
Centene
CNC
$30.1B
$13.1M 0.51%
250,000
-766,400
-75% -$41.4M
THC icon
43
Tenet Healthcare
THC
$20.3B
$8.8M 0.34%
+425,820
New +$9.81M
PSNL icon
44
Personalis
PSNL
$1.31B
$8.14M 0.32%
+300,000
New +$8.48M
SYK icon
45
Stryker
SYK
$133B
$6.86M 0.27%
+33,350
New +$6.37M
ADPT icon
46
Adaptive Biotechnologies
ADPT
$3.85B
$5.8M 0.22%
+120,000
New +$5.32M
IRWD icon
47
Ironwood Pharmaceuticals
IRWD
$614M
$5.47M 0.21%
500,000
-392,154
-44% -$4.39M
NGM
48
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5.01M 0.19%
+342,579
New +$5.01M
PTE
49
DELISTED
PolarityTE, Inc. Common Stock
PTE
$3.28M 0.13%
23,000
+7,000
+44% +$1.33M
ACAD icon
50
Acadia Pharmaceuticals
ACAD
$4.55B
$3.19M 0.12%
+119,484
New +$3.05M
1
2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2019 Portfolio in Review

As of Q2 2019, HealthCor Management held 71 positions worth $2.58B, up 4.1% from $2.48B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

HealthCor Management's Q2 2019 filing shows 22 new, 18 increased, 11 reduced and 19 closed positions. Its largest new stake was Edwards Lifesciences: 1,866,690 shares worth $115M. The largest sale was Zimmer Biomet, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 87% a quarter earlier, followed by Technology.

  • HealthCor Management's largest Q2 2019 buy was Edwards Lifesciences: 1,866,690 shares worth $115M.
  • HealthCor Management added most to Humana in Q2 2019, an estimated $98.1M increase.
  • HealthCor Management's biggest Q2 2019 reduction was Haemonetics, cutting an estimated $99.1M.
  • HealthCor Management fully exited Zimmer Biomet in Q2 2019, selling an estimated $136M.
  • HealthCor Management's ten largest holdings make up 46% of its $2.58B portfolio in Q2 2019.
  • HealthCor Management opened 22 new positions and closed 19 in Q2 2019.
  • HealthCor Management's portfolio value rose 4.1% quarter-over-quarter to $2.58B.

Based on HealthCor Management's 13F filing for Q2 2019, filed 14 Aug 2019.